These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38729565)

  • 1. Retrospective study to investigate appropriate duration of antibiotic treatment for uncomplicated Staphylococcus aureus bacteremia in patients with immunodeficiency.
    Shibata Y; Asai N; Hirai J; Mori N; Hagihara M; Mikamo H
    J Infect Chemother; 2024 Nov; 30(11):1141-1146. PubMed ID: 38729565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia (SAB7): study protocol for a randomized controlled trial.
    Thorlacius-Ussing L; Andersen CØ; Frimodt-Møller N; Knudsen IJD; Lundgren J; Benfield TL
    Trials; 2019 May; 20(1):250. PubMed ID: 31046810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between treatment duration and mortality or relapse in adult patients with Staphylococcus aureus bacteraemia: a retrospective cohort study.
    Abbas M; Rossel A; de Kraker MEA; von Dach E; Marti C; Emonet S; Harbarth S; Kaiser L; Uçkay I
    Clin Microbiol Infect; 2020 May; 26(5):626-631. PubMed ID: 31357013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of delayed appropriate antimicrobial therapy on children with Staphylococcus aureus blood infection.
    Guo Z; Xu X; Zhang G; Wang X; Tian X; Li Y; Li Q; Chen D; Luo Z
    Eur J Pediatr; 2024 Sep; 183(9):3785-3796. PubMed ID: 38874791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The benefits and safety of oral sequential antibiotic therapy in non-complicated and complicated Staphylococcus aureus bacteremia.
    Pérez-Rodríguez MT; Sousa A; Moreno-Flores A; Longueira R; Diéguez P; Suárez M; Lima O; Vasallo FJ; Álvarez-Fernández M; Crespo M
    Int J Infect Dis; 2021 Jan; 102():554-560. PubMed ID: 33157291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment duration for uncomplicated Staphylococcus aureus bacteremia to prevent relapse: analysis of a prospective observational cohort study.
    Chong YP; Moon SM; Bang KM; Park HJ; Park SY; Kim MN; Park KH; Kim SH; Lee SO; Choi SH; Jeong JY; Woo JH; Kim YS
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1150-6. PubMed ID: 23254436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of inappropriate empirical antibiotic therapy in patients with Staphylococcus aureus bacteraemia: analytical strategy using propensity scores.
    Kim SH; Park WB; Lee CS; Kang CI; Bang JW; Kim HB; Kim NJ; Kim EC; Oh MD; Choe KW
    Clin Microbiol Infect; 2006 Jan; 12(1):13-21. PubMed ID: 16460541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long versus short course anti-microbial therapy of uncomplicated Staphylococcus aureus bacteraemia: a systematic review.
    Schnizer M; Schellong P; Rose N; Fleischmann-Struzek C; Hagel S; Abbas M; Payne B; Evans RN; Pletz MW; Weis S
    Clin Microbiol Infect; 2024 Oct; 30(10):1254-1260. PubMed ID: 38823452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vancomycin MIC Does Not Predict 90-Day Mortality, Readmission, or Recurrence in a Prospective Cohort of Adults with Staphylococcus aureus Bacteremia.
    Baxi SM; Clemenzi-Allen A; Gahbauer A; Deck D; Imp B; Vittinghoff E; Chambers HF; Doernberg S
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5276-84. PubMed ID: 27324762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staphylococcus aureus bacteraemia--Nationwide assessment of treatment adequacy and outcome.
    Asgeirsson H; Kristjansson M; Kristinsson KG; Gudlaugsson O
    J Infect; 2011 May; 62(5):339-46. PubMed ID: 21402101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of a pharmacist-driven care package on Staphylococcus aureus bacteremia management in a large community healthcare network: A propensity score-matched, quasi-experimental study.
    Smith JR; Frens JJ; Snider CB; Claeys KC
    Diagn Microbiol Infect Dis; 2018 Jan; 90(1):50-54. PubMed ID: 29153470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality predictors of Staphylococcus aureus bacteremia: a prospective multicenter study.
    Yilmaz M; Elaldi N; Balkan İİ; Arslan F; Batırel AA; Bakıcı MZ; Gozel MG; Alkan S; Çelik AD; Yetkin MA; Bodur H; Sınırtaş M; Akalın H; Altay FA; Şencan İ; Azak E; Gündeş S; Ceylan B; Öztürk R; Leblebicioglu H; Vahaboglu H; Mert A
    Ann Clin Microbiol Antimicrob; 2016 Feb; 15():7. PubMed ID: 26860463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia.
    Kim SH; Kim KH; Kim HB; Kim NJ; Kim EC; Oh MD; Choe KW
    Antimicrob Agents Chemother; 2008 Jan; 52(1):192-7. PubMed ID: 17984229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Oral Antibiotic Switch in Staphylococcus aureus Bacteraemia: The Staphylococcus aureus Network Adaptive Platform (SNAP) Trial Early Oral Switch Protocol.
    de Kretser D; Mora J; Bloomfield M; Campbell A; Cheng MP; Guy S; Hensgens M; Kalimuddin S; Lee TC; Legg A; Mahar RK; Marks M; Marsh J; McGlothin A; Morpeth SC; Sud A; Ten Oever J; Yahav D; Bonten M; Bowen AC; Daneman N; van Hal SJ; Heriot GS; Lewis RJ; Lye DC; McQuilten Z; Paterson DL; Owen Robinson J; Roberts JA; Scarborough M; Webb SA; Whiteway L; Tong SYC; Davis JS; Walls G; Goodman AL; ;
    Clin Infect Dis; 2024 Oct; 79(4):871-887. PubMed ID: 37921609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Oral Switch to Linezolid for Low-risk Patients With Staphylococcus aureus Bloodstream Infections: A Propensity-matched Cohort Study.
    Willekens R; Puig-Asensio M; Ruiz-Camps I; Larrosa MN; González-López JJ; Rodríguez-Pardo D; Fernández-Hidalgo N; Pigrau C; Almirante B
    Clin Infect Dis; 2019 Jul; 69(3):381-387. PubMed ID: 30351401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of patient characteristics, clinical management, infectious specialist consultation, and outcome in men and women with methicillin-sensitive Staphylococcus aureus bacteremia: a propensity-score adjusted retrospective study.
    Forsblom E; Kakriainen A; Ruotsalainen E; Järvinen A
    Infection; 2018 Dec; 46(6):837-845. PubMed ID: 30194636
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Berrevoets MAH; Kouijzer IJE; Slieker K; Aarntzen EHJG; Kullberg BJ; Oever JT; Bleeker-Rovers CP
    J Nucl Med; 2019 Jul; 60(7):998-1002. PubMed ID: 30552202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Endovascular Staphylococcus aureus Inoculum Is the Link Between Elevated Serum Interleukin 10 Concentrations and Mortality in Patients With Bacteremia.
    Rose WE; Shukla SK; Berti AD; Hayney MS; Henriquez KM; Ranzoni A; Cooper MA; Proctor RA; Nizet V; Sakoulas G
    Clin Infect Dis; 2017 May; 64(10):1406-1412. PubMed ID: 28205673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time to blood culture positivity in Staphylococcus aureus bacteremia: association with 30-day mortality.
    Kim J; Gregson DB; Ross T; Laupland KB
    J Infect; 2010 Sep; 61(3):197-204. PubMed ID: 20547181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staphylococcus aureus bacteremia: predictors of 30-day mortality in a large cohort.
    Mylotte JM; Tayara A
    Clin Infect Dis; 2000 Nov; 31(5):1170-4. PubMed ID: 11073748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.